BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 29109372)

  • 1. Marine Algae as Source of Novel Antileishmanial Drugs: A Review.
    Tchokouaha Yamthe LR; Appiah-Opong R; Tsouh Fokou PV; Tsabang N; Fekam Boyom F; Nyarko AK; Wilson MD
    Mar Drugs; 2017 Oct; 15(11):. PubMed ID: 29109372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manzamine alkaloids as antileishmanial agents: A review.
    Ashok P; Lathiya H; Murugesan S
    Eur J Med Chem; 2015 Jun; 97():928-36. PubMed ID: 25023608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of new antileishmanial drugs--current knowledge and future prospects.
    Le Pape P
    J Enzyme Inhib Med Chem; 2008 Oct; 23(5):708-18. PubMed ID: 18671165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
    Da Silva BJM; Hage AAP; Silva EO; Rodrigues APD
    J Integr Med; 2018 Jul; 16(4):211-222. PubMed ID: 29691188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
    Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
    Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of nanotechnology in treatment of leishmaniasis: A Review.
    Akbari M; Oryan A; Hatam G
    Acta Trop; 2017 Aug; 172():86-90. PubMed ID: 28460833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches to discover marine antileishmanial natural products.
    Tempone AG; Martins de Oliveira C; Berlinck RG
    Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmaniasis: current treatment and prospects for new drugs and vaccines.
    Kedzierski L; Sakthianandeswaren A; Curtis JM; Andrews PC; Junk PC; Kedzierska K
    Curr Med Chem; 2009; 16(5):599-614. PubMed ID: 19199925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-derived compounds in treatment of leishmaniasis.
    Oryan A
    Iran J Vet Res; 2015; 16(1):1-19. PubMed ID: 27175144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmaniasis: current status of available drugs and new potential drug targets.
    Singh N; Kumar M; Singh RK
    Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial Drug Discovery: Synthetic Methods, Chemical Characteristics, and Biological Potential of Quinazolines and its Derivatives.
    Sahu A; Kumar D; Agrawal RK
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):3-32. PubMed ID: 28464778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational approaches for drug designing against leishmaniasis.
    Shukla AK; Singh BK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and new discoveries in the treatment of leishmaniasis.
    Singh S; Sivakumar R
    J Infect Chemother; 2004 Dec; 10(6):307-15. PubMed ID: 15614453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial patents antileishmanial current drugs and relevant patents.
    Monzote L
    Recent Pat Antiinfect Drug Discov; 2011 Jan; 6(1):1-26. PubMed ID: 21192776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis.
    Pal R; Teli G; Akhtar MJ; Matada GSP
    Eur J Med Chem; 2023 Oct; 258():115609. PubMed ID: 37421889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.
    Roseboom IC; Rosing H; Beijnen JH; Dorlo TPC
    Biomed Chromatogr; 2023 Jul; 37(7):e5519. PubMed ID: 36208186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do bismuth complexes hold promise as antileishmanial drugs?
    Ong YC; Kedzierski L; Andrews PC
    Future Med Chem; 2018 Jul; 10(14):1721-1733. PubMed ID: 29961352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
    Ortega V; Giorgio S; de Paula E
    J Liposome Res; 2017 Sep; 27(3):234-248. PubMed ID: 28874072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.